Celldex Therapeutics Inc. (CLDX)
Market Closed
17 Jul, 20:00
$
35. 35
-0.05
-0.1412%
$
2.54B Market Cap
- P/E Ratio
- Div Yield
1.15M Volume
-3.01 Eps
$ 35.4
Previous Close 
Want to track CLDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Celldex Therapeutics Inc. (CLDX) Statistics
Valuation metrics
Market Cap 2.54B
Enterprise value 2.32B
Trailing P/E (ttm) -8.28
Forward P/E -
PEG ratio 0.2
Price/Sales (ttm) 2,868.46
Price/Book (mrq) 5.16
Enterprise Value/Revenue 2,827.21
Enterprise Value/EBITDA -8.27
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 769.88K
Average volume (90 days) 810.77K
Price summary
52-Week low 19.72
52-Week high 40.3
Beta -
50-Day moving average 35.13
200-Day moving average 29.91
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 11 Feb 2019
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -345.96%
Operating margin -376.95%
Operational effectiveness
Return on assets -0.55%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.01
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -4.26
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.78
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 8.92%
Book value per share (mrq) 6.85
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
